Science Pool

Are TripleTOFs the Future for HT-ADME/Toxicity Screening?

Posted by Evotec on Feb 12, 2021 8:34:02 PM

LC-MS provides the analytical endpoint for most discovery ADME assays. There is a constant drive to reduce LC-MS run times whilst maintaining quality. 

In this presentation, we focus on:

  • a comparison of triple quadrupole MS/MS vs TripleTOF MS
  • validation data for performance of the TripleTOF MS 
  • use of the TripleTOF in high throughput ADME screening including intrinsic clearance assays and soft spot analysis.

View the presentation to learn more!

LEARN MORE

 

 

 

Tags: Presentations, ADME/DMPK